Amgen實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

Amgen 新聞

林芷柔 2026 Apr 01, 00:00

伊朗霍爾木茲戰略:槓桿封鎖水道以獲取經濟籌碼與全球影響

許景桓 2026 Apr 01, 00:00

黃金市場韌性:應對拋售並延續牛市行情

林芷柔 2026 Apr 01, 00:00

Meta 平台:駕馭法律挑戰與 AI 機遇,尋求投資者潛力

盧昕穎 2026 Apr 01, 00:00

地緣政治緩和與投資者佈局轉變,美股有望迎來反彈契機

許景桓 2026 Mar 28, 00:00

地緣政治動盪重塑美元策略,挑戰其傳統主導地位

黃達傑 2025 Oct 09, 16:00

臺灣值得關注的加密貨幣:比特幣(BTC)、以太坊(ETH)、索拉納(Solana,SOL)、零幣(Zcash,ZEC)

黃達傑 2025 Sep 29, 16:00

NIO 股票預測:NIO 今天下跌 5%,未來會怎樣?

黃達傑 2025 Sep 27, 16:00

比特幣價格預測:如何在台灣購買比特幣?

黃達傑 2025 Sep 23, 16:00

Fintech 股票值得關注:Nu Holdings(NU)股票、SOFI 股票

黃達傑 2025 Sep 21, 16:00

QBTS 股票今天上漲 11%:D-Wave Quantum Inc. 發生了什麼事?

最新新聞

顯示更多
許景桓 2026 Apr 01, 00:00

伊朗戰事牽動共和黨未來:特朗普政治遺產與接班人選的角力

林芷柔 2026 Apr 01, 00:00

全國「停止君主」集會:抗議移民、伊朗政策與其他行動

許景桓 2026 Apr 01, 00:00

烏克蘭尋求中東新盟友,善用國防專長

許景桓 2026 Apr 01, 00:00

美軍增兵中東 應對伊朗緊張局勢升級

張瑋庭 2026 Apr 01, 00:00

聯準會政策轉向:通膨風險抬頭,升息可能性浮現,市場預期動搖

盧昕穎 2026 Apr 01, 00:00

道達爾能源三月稱霸中東原油市場,創下驚人利潤紀錄

許景桓 2026 Apr 01, 00:00

地緣政治緊張加劇推升油價,布倫特原油逼近歷史月漲幅紀錄

林芷柔 2026 Apr 01, 00:00

美國市場本週焦點:聯準會主席鮑爾發言,勞動數據與經濟不確定性牽動市場

聯絡方式

點差

2.14

點差(%)

0.6071 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期四

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

189670948864

流通股份

539067675

收益日期(下一個)

1999-11-22

現金殖利率 

2026-06-05

除息日

2026-05-15

遠期年股息率

10.08

遠期年現金殖利率

0.0286

每股盈餘

14.21

了解有關此金融工具的詳細資訊

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
林芷柔 2025 Oct 29, 16:00

進階交易策略:多頭部位 vs. 空頭部位,哪個更好?

黃達傑 2025 Oct 13, 16:00

Palantir(PLTR)股價預測:PLTR暴跌5%,Palantir股價會再度飆升嗎?

黃達傑 2025 Oct 13, 16:00

Nvidia(NVDA)股價今日走高:2026年目標價是多少?

Trustpilot